Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yjmcc.2014.07.007PMID 25108227PMCID PMC4157969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

  2014cited by this paper
• Acetylsalicylic Acid Inhibits IL‐18‐Induced Cardiac Fibroblast Migration Through the Induction of RECK

  2014cited by this paper
• Interleukin-18 and IL-18 Binding Protein

  2013cited by this paper
• TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiation.

  2013cited by this paper
• Cardiac matrix: a clue for future therapy.

  2013cited by this paper
• Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].

  2013cited by this paper
• CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.

  2012cited by this paper
• β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

  2012cited by this paper
• Interleukin‐18/WNT1‐inducible signaling pathway protein‐1 signaling mediates human saphenous vein smooth muscle cell proliferation

  2011cited by this paper
• Effects of interleukin-18 on cardiac fibroblast function and gene expression.

  2011cited by this paper
• Stretch-Induced Hypertrophy Activates NFkB-Mediated VEGF Secretion in Adult Cardiomyocytes

  2011cited by this paper
• Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).

  2011cited by this paper
• Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes.

  2010cited by this paper
• Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).

  2010cited by this paper
• Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation.

  2010cited by this paper
• IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.

  2009influential reference
• The effect of daily administration of IL-18 on cardiac structure and function

  2008cited by this paper
• Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload.

  2007cited by this paper
• Vascular endothelial growth factor delays onset of failure in pressure–overload hypertrophy through matrix metalloproteinase activation and angiogenesis

  2006cited by this paper
• Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.

  2006cited by this paper
• Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-κB- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by Atorvastatin*

  2006cited by this paper
• Interleukin-18 Is a Pro-hypertrophic Cytokine That Acts through a Phosphatidylinositol 3-Kinase-Phosphoinositide-dependent Kinase-1-Akt-GATA4 Signaling Pathway in Cardiomyocytes*

  2005cited by this paper
• Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice.

  2005cited by this paper
• Activation of Intrinsic and Extrinsic Proapoptotic Signaling Pathways in Interleukin-18-mediated Human Cardiac Endothelial Cell Death*

  2004cited by this paper
• Evidence for altered interleukin (IL)‐18 pathway in human heart failure

  2004influential reference
• β-Adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB

  2004cited by this paper
• Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

  2004cited by this paper
• Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB.

  2004cited by this paper
• TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation.

  2003cited by this paper
• Inflammatory mediators and the failing heart: a translational approach.

  2003cited by this paper
• Noninvasive Serial Evaluation of Myocardial Mechanics in Pressure Overload Hypertrophy of Rabbit Myocardium

  2003cited by this paper
• TNF-α and H2O2 induce IL-18 and IL-18Rβ expression in cardiomyocytes via NF-κB activation

  2003cited by this paper
• The structure and binding mode of interleukin-18

  2003cited by this paper
• Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.

  2002cited by this paper
• Interleukin-18 promotes sleep in rabbits and rats.

  2001cited by this paper
• Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.

  2000cited by this paper
• Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol.

  2000cited by this paper
• Apoptosis and heart failure: A critical review of the literature.

  2000cited by this paper
• Role of oxidative stress in cardiovascular diseases

  2000cited by this paper
• Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure.

  1999cited by this paper
• Apoptosis in the failing human heart.

  1997cited by this paper
• Mechanotransduction in stretch-induced hypertrophy of cardiac myocytes.

  1993cited by this paper
• Isolation and characterization of rabbit cardiac endothelial cells: response to cyclic strain and growth factors in vitro.

  1992cited by this paper

• Efficacy of low dose colchicine on left ventricular hypertrophy in patients with coronary artery disease: A randomized controlled trial.

  2026cites this paper
• Inflammatory cardiomyopathy: a comprehensive review of biomarkers and future therapeutic perspectives

  2025cites this paper
• NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity

  2025cites this paper
• INTERLEUKIN-18 AS A THERAPEUTIC TARGET FOR WESTERN DIET-INDUCED CARDIOMYOPATHY

  2025cites this paper
• Research progress on programmed cell death of cardiomyocytes in pressure-overload hypertrophic cardiomyopathy

  2025cites this paper
• Nonpharmacological Approaches to Managing Heart Failure With Preserved Ejection Fraction

  2024cites this paper
• New and future heart failure drugs

  2024cites this paper
• Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy

  2024cites this paper
• Large animal models of pressure overload-induced cardiac left ventricular hypertrophy to study remodelling of the human heart with aortic stenosis

  2024cites this paper
• Quantifying inflammation using interleukin‐6 for improved phenotyping and risk stratification in acute heart failure

  2023cites this paper
• Acute Pancreatitis and Myocardial Infarction: A Narrative Review

  2023cites this paper
• Insulin-like growth factor 1 enhances follicle-stimulating hormone-induced phosphorylation of GATA4 in rat granulosa cells.

  2022cites this paper
• The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan.

  2022cites this paper
• Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications

  2022influential citation
• Inflammation in Metabolic Cardiomyopathy

  2021cites this paper
• Mechanobiological Principles Influence the Immune Response in Regeneration: Implications for Bone Healing

  2021cites this paper
• In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling

  2021cites this paper
• FONTAN CIRCULATION MIGHT BE ASSOCIATED WITH PERIPARTUM CARDIOMYOPATHY: A REVIEW OF MECHANISTIC AND CLINICAL ASPECTS.

  2021cites this paper
• Systemic inflammation in patients with Takotsubo syndrome: a review of mechanistic and clinical implications.

  2021cites this paper
• Caspase-1 Abrogates the Salutary Effects of Hypertrophic Preconditioning in Pressure Overload Hearts via IL-1β and IL-18

  2021cites this paper
• Risk assessment model for heart failure in Chinese patients with Takayasu’s arteritis

  2021cites this paper
• Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury – A Narrative Review

  2021cites this paper
• Systemic inflammation in TTS: Primary sources and triggers

  2021cites this paper
• Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia/reperfusion injury by transcriptional activation of CXCL16.

  2021cites this paper
• Degenerative changes of the aortic valve during left ventricular assist device support

  2021cites this paper
• Sodium Glucose Cotransporter 1 (SGLT1) Inhibitors in Cardiovascular Protection: Mechanism Progresses and Challenges.

  2021cites this paper
• Echocardiographic Results of Myocardial Revascularization Depending on the Genetic Polymorphism of Inflammatory Cytokines

  2020cites this paper
• Risk factors for the adverse cardiac outcomes in the patients with Takayasu’s arteritis.

  2020cites this paper
• Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications

  2020cites this paper
• Chemokines profile in patients with chronic heart failure treated with cardiac resynchronization therapy.

  2020cites this paper
• Proinflammatory Cytokines in Acute Coronary Syndromes.

  2020cites this paper
• The NLRP3 inflammasome in acute myocardial infarction.

  2019cites this paper
• Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy

  2019cites this paper
• Role of interleukins in heart failure with reduced ejection fraction

  2019cites this paper
• Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases

  2019cites this paper
• Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure

  2019cites this paper
• EFFECTS OF THE NA-CL CO-TRANSPORTER (NCC) IN WESTERN DIET INDUCED METABOLIC AND CARDIAC DYSFUNCTION

  2018cites this paper
• Low‐level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction

  2018cites this paper
• Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice.

  2018cites this paper
• Inflammation in Right Ventricular Failure: Does It Matter?

  2018cites this paper
• Inflammation – Cause or Consequence of Heart Failure or Both?

  2017cites this paper
• Circulating IL-18 Binding Protein (IL-18BP) and IL-18 as Dual Biomarkers of Total-Body Irradiation in Mice

  2016cites this paper
• HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload

  2016cites this paper
• Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress.

  2016cites this paper
• The Role of Proinflammatory Cytokine Interleukin-18 in Radiation Injury

  2016cites this paper
• Mitogen‐activated protein kinase p38 target regenerating islet‐derived 3γ expression is upregulated in cardiac inflammatory response in the rat heart

  2016cites this paper
• Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2.

  2015cites this paper
• Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling

  2015cites this paper